MedTrace Logo

COVID-Like Illness Respiratory Pathogens. A Prospective Cohort on the COVID-19 Post-acute Condition

NCT05047666 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1232

Last updated 2021-09-17

No results posted yet for this study

Summary

Identifying multiorgan sequalae and complications through high quality, prospective matched controlled studies throughout the course of COVID-19 is important for the acute and long-term management of patients and for health systems' planning. Further, it is key to understand the link between acute illness and long term consequences particularly in those already living with other comorbidities such as cardiovascular diseases or cancer.

Since the clinical presentation of COVID-19 can resemble a variety of common respiratory infections, describing the distribution of pathogens and the severity of clinical presentation associated with COVID-like illnesses (CLI) infections is important to generate a baseline clinical description by comparing potential long-term effects of PCR-confirmed COVID-19 to those following other respiratory infections.

To gain a better understanding of the clinical burden on COVID-19 survivors we will undertake a comparative evaluation within a cohort of PCR-confirmed individuals with COVID-19 vs. those PCR-confirmed symptomatic individuals with other respiratory pathogens plus healthy individuals from the community.

The results will inform strategies to prevent long term consequences; inform clinical management, interventional research, direct rehabilitation, and inform public health management to reduce overall morbidity and improve outcomes of COVID-19.

Conditions

  • Respiratory Infection
  • COVID-19 Respiratory Infection
  • Sequelae of; Infection

Sponsors & Collaborators

  • Kumasi Centre for Collaborative Research (KCCR)

    collaborator OTHER

  • Bernhard Nocht Institute for Tropical Medicine

    lead OTHER_GOV

Principal Investigators

  • Ricardo Strauss, Dr.MD. MPH · Bernhard Nocht Institute for Tropical Medicine

  • Jürgen May, Prof. Dr. · Bernhard Nocht Institute for Tropical Medicine

  • Oumou Maiga-Ascofare, PhD · Kumasi Center for Collaborative Research in Tropical Medicine

  • John Amuasi, MBChB, MPH, PhD · Kumasi Center for Collaborative Research in Tropical Medicine

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-31
Primary Completion
2022-10-31
Completion
2023-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05047666 on ClinicalTrials.gov